Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease
Fermentation · 23.06.2025 · 11 (7) · 362
DOI: 10.3390/fermentation11070362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fermentation, online erschienen am 23.06.2025. Verfasst von Emili Bruna Toso Bueno und 7 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterized by chronic inflammation in the gastrointestinal tract, which can result in several muscular complications, including sarcopenia, the loss of muscle mass, and impaired muscle function. Recently, postbiotics derived from lactic bacteria, such as Lactobacillus and Bifidobacterium, have emerged as potential therapeutic modulators for these complications. Postbiotics are bioactive metabolites, such as short-chain fatty acids (SCFAs), antimicrobial peptides, and other compounds produced by microorganisms during fermentation, which have anti-inflammatory, antioxidant, and metabolic regulatory effects. These metabolites are important due to their potential to positively influence muscle health in patients with IBD, mainly by reducing systemic and local inflammation, improving gut microbiota, and modulating muscle metabolism. Studies suggest that these postbiotics may help minimize muscle degradation and promote muscle tissue regeneration, assisting in the prevention or management of IBD-associated sarcopenia. Despite the promising results, challenges remain, such as variability in postbiotic production and the need for further clinical studies to establish clear therapeutic guidelines. This review article explores the mechanisms of action of postbiotics derived from lactic acid bacteria and their potential applications in the treatment of muscle complications in patients with IBD, highlighting future therapeutic perspectives.
Zitieren
APA
Bueno, E. B. T., Silva, K. D. O., Mendes, M. E. F., Oliveira, L. B. D., Menezes, F. P. D., Imperador, A. C., Correia, L. F., & Winkelstroter, L. K. (2025). Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease. Fermentation, 11(7), 362. https://doi.org/10.3390/fermentation11070362
Vancouver
Bueno EBT, Silva KDO, Mendes MEF, Oliveira LBD, Menezes FPD, Imperador AC, et al. Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease. Fermentation. 2025;11(7):362. doi:10.3390/fermentation11070362
BibTeX
@article{Bueno2025,
author = {Bueno, Emili Bruna Toso and Silva, Kimberlly de Oliveira and Mendes, Maria Eduarda Ferraz and Oliveira, Lívia Batista de and Menezes, Felipe Prado de and Imperador, Anna Cardoso and Correia, Lucimeire Fernandes and Winkelstroter, Lizziane Kretli},
title = {Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease},
journal = {Fermentation},
year = {2025},
volume = {11},
number = {7},
pages = {362},
doi = {10.3390/fermentation11070362}
}
EUVIMED